MedTrace Logo

Vitamin D for Chemoprevention

NCT00585637 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2015-04-01

Study results available
· View outcomes & findings →

Summary

This study will help us know the effects of Vitamin D pills in Blacks. The results of this study may be the first step in creating ways to prevent the risks of colon and prostate cancer. It will also help us develop ways to reduce colon cancer and prostate cancer among Blacks. This study will find out if Vitamin D pills can increase Vitamin D to healthy levels in our bodies.

Conditions

Interventions

DRUG

Vitamin D

Taken orally every day for three months

DIETARY_SUPPLEMENT

Placebo

Placebo pill taken once daily for 3 month

Sponsors & Collaborators

Principal Investigators

  • Edward Giovannucci, MD, ScD · Harvard School of Public Health/Brigham and Women's Hospital

  • Gary G Bennett, PhD · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-10-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585637 on ClinicalTrials.gov